Abbott Laboratories

ABT | NYSE | 47 Followers

$126.65

0.80%

$1.01

Overview Metrics Financials

Fair Price

$549.33

Overvalued by 79.1%

To display the fair price of a share, you need to be a member of Bulios Black.

Company Quality

Dividends

Earnings

My Notes

You haven't added any notes for this stock yet. Use this space to record your insights or strategies.

Profile

Abbott Laboratories (ABT) is an American healthcare company with a global presence. The company specializes in the development, manufacturing, and distribution of a wide range of healthcare products and medications. Abbott focuses on innovative pharmaceuticals, diagnostic equipment, medical devices, and nutritional products. Their portfolio includes products for various areas of healthcare, such as cardiovascular care, diabetes care, gastroenterology, infectious disease diagnostics, maternal and pediatric care, and many others. The company has a long history and is known for its quality, reliability, and research in healthcare innovations. Abbott Laboratories plays a crucial role in improving people's health worldwide and collaborates with physicians and healthcare professionals on the development of medications and diagnostic solutions. Abbott Laboratories (ABT) shares are an interesting choice for investors who follow the healthcare sector and seek investment opportunities in a key company operating in the healthcare industry.

Key Metrics TTM

Equity Peers

Performance

Earnings Waterfall

Debt level and coverage

Earnings

Feed

This $ABT stock news is available only to Bulios Black members.

Upgrade

ABT

$126.65

Abbott Laboratories

0.80%

This $ABT stock news is available only to Bulios Black members.

Upgrade

ABT

$126.65

Abbott Laboratories

0.80%

11M

This $ABT stock news is available only to Bulios Black members.

Upgrade

ABT

$126.65

Abbott Laboratories

0.80%

This $ABT stock news is available only to Bulios Black members.

Upgrade

ABT

$126.65

Abbott Laboratories

0.80%

Dragoslav Golob

@dragoslavgolob

Laboratorij Abbott je zaradi dobre prodaje medicinskih pripomočkov presegel pričakovanja glede četrtletnega dobička.

Posebej uspešna je bila prodaja izdelkov za spremljanje glukoze.

Povečanje povpraševanja po medicinskih posegih je podprlo splošno rast.

Letni dobiček v višini 98 centov na delnico je za 3 cente presegel ocene analitikov.

Abbott Laboratories $ABT0.8% je povišal celoletno...
Read more

Mladen Rudonja

@mladenrudonja

📈 Naložbeni dragulji v zdravstvu 📈

Pozdravljeni BuliosiansDanes imam tukaj tri kralje zdravstvene industrije! 💰

Johnson & Johnson $JNJ
DružbaJNJ je zveč kot 62 leti stalnih dividend in bonitetno oceno AAAzanimiva izbira. Podjetje se osredotoča na farmacevtske izdelke, medicinske pripomočke in tehnologijo ter poudarja doslednost in trajnost. Zzgodovinsko nizkim prihodnjim P/E ...
Read more

Primoz Krajnc

@primozkrajnc

>2y

Še dobro, da sem Abbota kupil za 100 dolarjev. Rezultati so idealni kljub nižjim pričakovanjem za preostanek leta glede prodaje kovidskih izdelkov.

Abbott Laboratories

Fair Price

Company Quality

Dividends

Earnings

My Notes

Profile

Key Metrics TTM

Equity Peers

Performance

Earnings Waterfall

Debt level and coverage

Earnings

Feed

Log in to Bulios

Create Bulios profile

Why Bulios?